| For: | Dong WW, Liu T, He LX, He WT. Targeting pyroptosis in inflammatory bowel disease: A potentially effective therapeutic approach. World J Gastroenterol 2025; 31(43): 111358 [PMID: 41358180 DOI: 10.3748/wjg.v31.i43.111358] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i43/111358.htm |
| Number | Citing Articles |
| 1 |
Yuan-Ben Wang, Li Chen, Feng-Shang Zhu. New advances in biologics and small molecule drugs for treatment of inflammatory bowel disease. World Chinese Journal of Digestology 2026; 34(7) doi: 10.11569/wcjd.v34.i7.562
Abstract(88) |
Core Tip(75) |
Full Article(HTML)(1427)
|
Times Cited (0)
|
Total Visits (1641)
|
Open
|
| 2 |
Qian-qian Wang, Rong-ying Hou, Yi-xuan Shua, Ya-fei Xu, Wen-jing Bian, Wen Xiao, Yu-qing Chen, Bing-yu Zhou, Yue Gao, Li Liu, Yu-hang Wang, Yi-bei Xiao, Cheng Jiang. Discovery and characterization of PGC-01: An effective GSDMD-targeting PROTAC. European Journal of Medicinal Chemistry 2026; 319 doi: 10.1016/j.ejmech.2026.119294
|
| 3 |
Zhouxin Yu, Zhiqiang Zhao, Yushi Tian, Gengchen Xue, Jingbo Wang, Yuncong Li, Heng Fan. Macrophage pyroptosis in inflammatory bowel disease: mechanistic insights, pathological roles and treatment strategies. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1904376
|
| 4 |
Han-Xi Zhang, Wen-Jing Xu, Yi-Xin Jiang, Lu Li, Bai-Yu Chen, Meng-Yao Cheng, Meng-Yuan Hao, Hang-Shen Han, Hong-Jie Li, Yan-Ge Li, Dong-Dong Wu. Pyroptosis as a double-edged sword in colorectal cancer: Molecular mechanisms and therapeutic opportunities. Apoptosis 2026; 31(4) doi: 10.1007/s10495-026-02309-y
|
| 5 |
Caglar Berkel. Low ALIX expression might promote mucosal inflammation in the colon of patients with ulcerative colitis, possibly by promoting pyroptosis: an in silico analysis. Comparative Clinical Pathology 2026; 35(1) doi: 10.1007/s00580-026-03844-5
|
| 6 |
Hajara Babie Musa, Daniel Kofi Nyame, Tungalag Battulga, Mary Tariro Nyanhewe, Kexue Zhao, Zihan He, Benson Peter Mugaka, Ming Xu. Gasdermin D: a key mediator of inflammation in cardiovascular disease with a focus on atherosclerosis. Exploration of Cardiology 2026; 4 doi: 10.37349/ec.2026.1012112
|
| 7 |
John K. Triantafillidis, Stavros Karakatsanis. Treatment of Inflammatory Bowel Disease with Drugs Targeting PANoptosis: A Comprehensive Review. Biomedicines 2026; 14(1) doi: 10.3390/biomedicines14010148
|
| 8 |
Yang Han, Jianbao Zheng, Jian Dong, Hui Cai, Longlong Cong, Lin Yang. Bisphenol A aggravates colitis-associated intestinal epithelial injury: Mitochondrial dysfunction and CASP1-associated inflammatory signaling. Ecotoxicology and Environmental Safety 2026; 323 doi: 10.1016/j.ecoenv.2026.120744
|
| 9 |
Xiangchun Zhou, Zhijun Wu, Lu Cai, Meng Liu, Benyin Lu. Regulatory mechanisms and therapeutic targets of programmed cell death in intestinal epithelial cells in inflammatory bowel disease. Tissue and Cell 2027; 104 doi: 10.1016/j.tice.2026.103877
|